Presentation by Beth McCoy, Pfizer: Qualification of the Platform Multi-Attribute Method (MAM) at Pfizer
Presentation by Beth McCoy, Pfizer: Qualification of the Platform Multi-Attribute Method (MAM) at Pfizer
Loading view.
Presentation by Annick Gervais, Eef Dirksen, Thomas Pohl, EFPIA: Regulatory Considerations for the Applications of Multi-Attribute Method by Mass Spectrometry for QC Release and Stability Testing of Biopharmaceuticals
Presentation by Annick Gervais, Eef Dirksen, Thomas Pohl, EFPIA: Regulatory Considerations for the Applications of Multi-Attribute Method by Mass Spectrometry…
Presentation by Angela Criscuolo and Alexander A. Makarov, Thermo Fisher Scientific: iMAM: MAM on the Intact Protein Level – Measurement of Molecular Elephants and Whales by Orbitrap Mass Spectrometry
Presentation by Angela Criscuolo and Alexander A. Makarov, Thermo Fisher Scientific: iMAM: MAM on the Intact Protein Level - Measurement…
Presentation by Dan Bach Kristensen, Symphogen: Addressing Missed Cleavages and Chromatographic Peak Tailing/Carry-over in MAM Workflows
Presentation by Dan Bach Kristensen, Symphogen: Addressing Missed Cleavages and Chromatographic Peak Tailing/Carry-over in MAM Workflows
Presentation by Da Ren, BioTherapeutics Solutions: MAM, An Eight Year Overview
Presentation by Da Ren, BioTherapeutics Solutions: MAM, An Eight Year Overview
Presentation by Krisztina Radi & Ilker Sen, Protein Metrics: Spotting the Outliers in MAM Runs Automatically with Deep Query and Dashboards
Presentation by Krisztina Radi & Ilker Sen, Protein Metrics: Spotting the Outliers in MAM Runs Automatically with Deep Query and…
Presentation by Hirsh Nanda, Janssen: Lab-of-the-Future: A Robotic and Cloud-Based Analytical Pipeline for High-Throughput Characterization of Biologics
Presentation by Hirsh Nanda, Janssen: Lab-of-the-Future: A Robotic and Cloud-Based Analytical Pipeline for High-Throughput Characterization of Biologics
Presentation by Jennifer Zhang, Genentech: Enabling MAM for Control System Testing: A Case Study for Commercial Launch Readiness
Presentation by Jennifer Zhang, Genentech: Enabling MAM for Control System Testing: A Case Study for Commercial Launch Readiness
Presentation by Brian Gau, Pfizer: Oligonucleotide Mapping via LC-UV-MS/MS to Enable Comprehensive Primary Structure Characterization of mRNA Drug Substance
Presentation by Brian Gau, Pfizer: Oligonucleotide Mapping via LC-UV-MS/MS to Enable Comprehensive Primary Structure Characterization of mRNA Drug Substance
Presentation by Sarah Rogstad, FDA: The Use of Mass Spectrometry in Therapeutic Protein Biologics License Applications: A Retrospective Review Revisited
Presentation by Sarah Rogstad, FDA: The Use of Mass Spectrometry in Therapeutic Protein Biologics License Applications: A Retrospective Review Revisited